-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614.P1.46 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I

Symposia: Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Hyery Kim, MD1, Jung Yoon Choi2,3*, Sung Han Kang, MD1*, Kyung Nam Koh, MD, MS1*, Kyung Taek Hong, MD3,4, Hee Young Ju, MD5*, Keon Hee Yoo, MD, PhD5*, Sunmin Yun6*, Yoomi Park6*, Ju Han Kim, MD, PhD6*, Hyoung Jin Kang, MD, PhD3,7 and Ho Joon Im, MD, PhD1*

1Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
2Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea
3Seoul National University Cancer Research Institute, Seoul, Korea, Republic of (South)
4Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
5Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
6Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
7Department of Pediatrics, Seoul National University College of Medicine and Hospital, Seoul, Korea, Republic of (South)

Luke Maese, DO1, Mignon L. Loh, MD2, Mi Rim Choi3*, Tong Lin3*, Etsuko Aoki3*, Shirali Agarwal3*, Vijayalakshmi Chandrasekaran4*, Yali Liang4*, Suzette Girgis4*, Cuiping Chen3*, Robert Iannone4*, Lewis B. Silverman, MD5, Elizabeth A. Raetz6* and Rachel E. Rau2*

1University of Utah, Primary Children’s Hospital, Salt Lake City, UT
2Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA
3Jazz Pharmaceuticals, Palo Alto, CA
4Jazz Pharmaceuticals, Philadelphia, PA
5Dana-Farber Cancer Institute, Boston Children’s Hospital, Boston, MA
6New York University Langone Medical Center, New York, NY

Anjali S. Advani, MD1, Anna B Moseley, MS2,3*, Kristen M. O'Dwyer, MD4, Brent L. Wood, MD, PhD5, Jae H. Park, MD6, Matthew J. Wieduwilt, MD7*, Deepa Jeyakumar, MD8, George Yaghmour, MD9, Ehab L. Atallah, MD10, Aaron T. Gerds, MD, MS11, Susan M. O'Brien12, Jane L. Liesveld, MD13, Megan Othus, PhD3,14, Mark R. Litzow, MD15, Richard M Stone, MD16, Elad Sharon, MD, MPH17*, Cecilia C.S. Yeung, MD2, Jerald P. Radich, MD18 and Harry P. Erba, MD, PhD19

1Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Fred Hutchinson Cancer Center, Seattle, WA
3SWOG Statistics and Data Mangement Center, Seattle, WA
4University of Rochester, Rochester, NY
5Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
6Memorial Sloan Kettering Cancer Center, New York, NY
7Atrium Health Wake Forest Baptist, Winston Salem, NC
8Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
9USC Norris Comprehensive Cancer Center, Los Angeles, CA
10Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
11Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
12Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
13James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
14Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA
15Division of Hematology, Mayo Clinic, Rochester, MN
16Dana-Farber Cancer Institute, Boston, MA
17NCI Cancer Therapy Evaluation program (CTEP), Bethesda, MD
18Translational Sciences & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
19Duke Cancer Institute, Durham, NC

Jayastu Senapati, MD, MBBS, DM1, Elias Jabbour2, Nicholas J. Short, MD1, Guilin Tang, MD PhD3*, Fadi G. Haddad, MD1*, Nitin Jain, MD1, Ghayas C. Issa4, Tapan M. Kadia, MD1, Naval Daver, MD1, Alessandra Ferrajoli, MD1, Monica Kwari, BSN5*, Guillermo Garcia-Manero, MD1*, Guillermo Montalban-Bravo, MD1, Patrice Eric Nasnas, MD6*, Naveen Pemmaraju, MD1, Rebecca Garris1*, Farhad Ravandi, MD, MBBS1 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Leukemia, MD Anderson Cancer Center, Houston, TX
6Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Han-Yu Cao1*, Lu-Lu Chen2*, Chao-Ling Wan3*, Xiao-Hui Hu4*, Bing Wu5*, Li Yang6*, Li Wang7*, Yang Zhang8*, De-Pei Wu9, Hai-Ping Dai4*, Hao Zhang2* and Shengli Xue4*

1The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
2Affiliated Hospital of Jining Medical University, Jining, China
3Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
4The First Affiliated Hospital of Soochow University, Suzhou, China
5Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China
6Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China
7Huai'an Second People's Hospital, Huai'an, China
8Canglang Hospital of Suzhou, Suzhou, China
9Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

Lars Fransecky1*, Walter Fiedler, MD2, Christoph Röllig, MD, MSc3*, Tim Sauer, MD4*, Simon Raffel, MD4*, Winfried Alsdorf5*, Lisa Heberling6*, Kumaran Nagarajan7*, Britta Steer7*, Philipp Nakov, MD8*, Björn Steffen, MD9*, Dorothee Deckbar10*, Sonja Bendig11*, Lorenz Bastian12*, Martin Neumann13*, Monika Brueggemann, PhD14*, Nicola Goekbuget, MD15 and Claudia D Baldus, MD1*

1Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
2University Hospital Hamburg-Eppendorf, Hamburg, DEU
3Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
4Heidelberg University Hospital, Heidelberg, Germany
5Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
6University Hospital Dresden, TU Dresden, Germany, Dresden, Germany
7UKSH Campus Kiel, Kiel, Germany
8University Hospital Schleswig Holstein Campus Kiel, Kiel, Germany
9Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany
10Goethe University Frankfurt, Frankfurt, Germany
11University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, DEU
12CATCH-ALL, UKSH Campus Kiel, Kiel, Germany
13Medical Department II, University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
14University Hospital Schleswig-Holstein, Kiel, DEU
15Goethe University Hospital, Frankfurt, Germany

Carlos Plaza, MD1*, Brenner Sabado, MD2*, Teodoro Chisesi, MD3*, Manuel A Granja, MD4*, Andrés Orquera, MD5*, Maria Augusta Pacheco, MD6*, Jairo Manuel Quiñonez, MD7*, Maria Del Carmen Trujillo, MD8*, Danilo A Navarrete, MD9*, Lorena Sanchez, MD10*, Johanna Ramírez, MD11* and Jorge Oliveros-Alvear, MD, MMSc2,12

1Hematology Department, SOLCA Guayaquil, Guayaquil, Guayas, Ecuador
2Hematology Department, Hospital Luis Vernaza, Guayaqul, Guayas, Ecuador
3HEMATOLOGY, FUNDACION ANGELA SERRA, GUAYAQUIL, GUAYAS, ECU
4Hematology Department, Hospital de Especialidades Carlos Andrade Marín, QUITO, PICHINCHA, ECU
5Hematology Department, Hospital de Especilidades Carlos Andrade Marín, QUITO, PICHINCHA, Ecuador
6Hematology Department, SOLCA Cuenca, Cuenca, Azuay, Ecuador
7Medicina Interna, Centro de Especialidades Médicas INRHED, samborondon, Guayas, Ecuador
8Hematology Department, Hospital Eugenio Espejo, Quito, Pichincha, ECU
9Hematology Department, SOLCA MANABI, PORTOVIEJO, MANABÍ, Ecuador
10HEMATOLOGY DEPARTMENT, HOSPITAL ABEL GILBERT PONTON, GUAYAQUIL, GUAYAQS, ECU
11Hospital de Especilidades Teodoro Mandonado Carbo, Guayaquil, Guayas, Ecuador
12Facultad de Medicina, Universidad de Guayaquil, Guayaqul, Ecuador

Ting Zhang1*, Kaibo Zhu2*, Cai Zihong3*, Ren Lin2,4*, Qifa Liu, MD5 and Hongsheng Zhou6,7*

1zhangtashley@hotmail.com, Guangzhou, China
2Nanfang Hospital, Guangzhou, China
3Nanfang Hospital, Southern Medical University,, Guangzhou, China
4lansinglinren@163.com, Guangzhou, China
5Department of Hematology, Nanfang Hospital, Southern medical university CN, Guangzhou, China
6Nanfang Hospital, Southern Medical University, Guangzhou, China
7Nanfang Hospital, Southern Medical University, Guangzhou, CHN

Libai Chen, MD*, Huiyan Yang*, Lei Zhang*, Yongsheng Ruan, MD, Jianyun Wen* and Xuedong Wu, MD*

Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China

Yan-yan Li1*, Hai-xia Zhou2*, Si-man Huang2*, Chao-Ling Wan2*, Ming-zhu Xu2*, Wen-jie Gong2*, Chong-Sheng Qian2*, De-pei Wu3, Haiping Dai2* and Sheng-Li Xue4*

1The First Affiliated Hospital of Soochow University, Suzhou, AL, China
2The First Affiliated Hospital of Soochow University, Suzhou, China
3National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China, Suzhou, China
4Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China

Monia Lunghi, MD, PhD1*, Francesca Kaiser, MD2*, Deborah Cardinali, Bachelor in Science2*, Claudia Basilico, MD3*, Marzia Defina, MD4*, Sara Mastaglio, MD5*, Lazzarotto Davide, MD6*, Prassede Salutari, MD7*, Matteo Piccini, MD8*, Valeria Cardinali, MD9*, Antonio Pierini, MD, PhD10*, Nicola Fracchiolla, MD11*, Federica Di Biase, MD12*, Mario Annunziata, MD13*, Mariangela Di Trani, Bachelor in Science2*, Felicetto Ferrara, MD14*, Giovanni Pizzolo, MD15*, Robin Foà, MD2* and Sabina Chiaretti, MD, PhD16

1Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
2Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
3Divisione di Ematologia, Ospedale di Circolo di Varese e Fondazione Macchi, ASST Sette Laghi, Varese, Italy
4Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy
5Hematology and Bone Marrow Transplant, Unit San Raffaele Scientific Institute, Milan, Italy
6Clinica Ematologica e Centro Trapianti, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy
7Department of Hematology, Ospedale Civile Spirito Santo, Pescara, Pescara, Italy
8SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy
9Università Di Perugia, Periglia, ITA
10Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
11Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
12Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
13Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli, Napoli, ITA
14Divisione di Ematologia, Ospedale Cardarelli, Napoli, Italy
15Department of Medicine, Hematology section, University of Verona, Verona, ITA
16Division of Hematology, Department of Translational and Precision Medicine, Division of Hematology, Rome, Italy

Trevor Jamison, MD1,2*, Hagop M. Kantarjian, MD3, Shilpa Paul, PharmD3*, Branko Cuglievan4, David McCall, MD5*, Nitin Jain, MD3, Fadi G. Haddad, MD3*, Kayleigh R. Marx, PharmD3*, Caitlin R Rausch, PharmD3*, J. Michael Savoy, PharmD4*, Lewis Nasr3*, Cedric Nasnas3*, Marianne Zoghbi3*, Rebecca Garris3*, Farhad Ravandi, MD, MBBS3, Marina Y. Konopleva3, Elias Jabbour3 and Nicholas J. Short, MD3

1Department of Medicine, Baylor College of Medicine, Missouri City, TX
2Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Division of Pediatrics, MD Anderson, Houston, TX

Marlise R. Luskin, MD1, Shai Shimony, MD2*, Julia Keating, MS3*, Yael Flamand, MS4*, Jacqueline S. Garcia, MD2, Rebecca Leonard2*, Thomas Reardon4*, Taylor Robertson4*, Chase M Weizer4*, Ilene Galinsky, ANP2, Donna S. Neuberg, ScD3, Richard M Stone, MD4, Eric S. Winer, MD4, Anthony G. Letai4, Mark Alan Murakami, MD, MA, MMSc4 and Daniel J. DeAngelo4

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA

Mark Blaine Geyer, MD1,2, John Mascarenhas, MD3*, Marissa Smith4*, Shakira Pascual2*, Anmol Shah2*, Michael R. Silvestrone2*, Tina Czaplinska3*, Kathryn Johnson, DNP, MSc, FNP-BC5*, Meghan C. Thompson, MD6 and Jae H. Park, MD6,7

1Department of Medicine, Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
4Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Nursing, Icahn School of Medicine at Mount Sinai, New York, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
7Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Nora Philipp1,2*, Anetta Marcinek, M.Sc.1,2*, Gerulf Hänel, Ph.D.1,2*, Daniel Nixdorf, MSc1,2*, Veit L. Buecklein, MD1,3* and Marion Subklewe, MD1,2,4

1Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
2Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
3Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
4German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Jessica T. Leonard, MD1, Rachel J. Cook, MD2, Laura F. Newell, MD3, Arpita Gandhi, MD4, Ronan T. Swords, MD, PhD, FRCP, FRCPath5, Christopher A. Eide3*, Brandon Hayes-Lattin, MD6, Kara Johnson7*, Elie Traer, MD, PhD8, Stephen E. Kurtz3*, Jennifer N. Saultz, DO3, Cristina Tognon, PhD7*, Jeffrey W Tyner, PhD3 and Curtis A Lachowiez, MD9

1Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
2Oregon Health and Science University, Portland, OR
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
5Knight Cancer Institute, Oregon Health and Science University, Portland, OR
6Knight Cancer Institute, Oregon Health Science University, Portland, OR
7Oregon Health & Science University, Portland, OR
8Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR
9Knight Cancer Institute, Oregon Health & Science University, Houston, TX

*signifies non-member of ASH